Conclusion:
Vaccine-related VZV reactivation was reported worldwide most commonly with mRNA vaccine while RHS is an uncommon condition. Most reported cases had a favorable outcome with total regression within a few days.
Data are limited to support a causal link between COVID-19 vaccines and herpes virus reactivation. Therefore, further epidemiologic studies are needed to assess the vaccine’s imputability.